DCM
APYX icon

Driehaus Capital Management’s Apyx Medical APYX Stock Holding History

Driehaus Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-521,516
Closed -$1.87M – 534
2016
Q4 		$1.87M Buy
+521,516
New +$2.32M 0.07% 268

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Driehaus Capital Management's APYX Position: Q1 2017 in Review

Driehaus Capital Management sold out of Apyx Medical (APYX) in Q1 2017, closing a stake of 521,516 shares — an estimated $1.87M sold.

Driehaus Capital Management first reported a position in APYX in Q4 2016 and held it in 1 quarter. The position peaked at $1.87M in Q4 2016. 37 funds tracked by Wall St. Rank hold APYX as of Q1 2017.

  • Driehaus Capital Management reported no remaining Apyx Medical position as of Q1 2017 after selling out during the quarter.
  • Driehaus Capital Management sold 521,516 Apyx Medical shares in Q1 2017, an estimated $1.87M.
  • Driehaus Capital Management first reported a position in Apyx Medical in Q4 2016 and held it in 1 quarter.
  • Driehaus Capital Management's Apyx Medical position peaked at $1.87M in Q4 2016.
  • 37 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2017.

Based on Driehaus Capital Management's 13F filing for Q1 2017, filed 16 May 2017.